ALCPB Fundamental Analysis - CAPITAL B

Fundamental Rating

Taking everything into account, ALCPB scores 4 out of 10 in our fundamental rating. ALCPB was compared to 115 industry peers in the Software industry. The financial health of ALCPB is average, but there are quite some concerns on its profitability. ALCPB is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALCPB had positive earnings in the past year.

ALCPB had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: ALCPB reported negative net income in multiple years.

Of the past 5 years ALCPB 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of ALCPB (4.00%) is comparable to the rest of the industry.

ALCPB's Return On Equity of 11.33% is in line compared to the rest of the industry. ALCPB outperforms 54.31% of its industry peers.

		Industry Rank	Sector Rank
ROA	4%
ROE	11.33%
ROIC	N/A

ROA(3y)-22.55%

ROA(5y)-12.7%

ROE(3y)-96.83%

ROE(5y)-38.45%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of ALCPB (9.81%) is comparable to the rest of the industry.

ALCPB's Profit Margin has been stable in the last couple of years.

ALCPB has a worse Gross Margin (60.18%) than 63.79% of its industry peers.

ALCPB's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	9.81%
GM	60.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y1.01%

GM growth 3Y3.05%

GM growth 5Y5.75%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALCPB does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALCPB has more shares outstanding than it did 1 year ago.

The number of shares outstanding for ALCPB has been increased compared to 5 years ago.

Compared to 1 year ago, ALCPB has an improved debt to assets ratio.

2.2 Solvency

ALCPB has an Altman-Z score of 4.04. This indicates that ALCPB is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of ALCPB (4.04) is comparable to the rest of the industry.

A Debt/Equity ratio of 0.29 indicates that ALCPB is not too dependend on debt financing.

The Debt to Equity ratio of ALCPB (0.29) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.29
Debt/FCF	N/A
Altman-Z	4.04

ROIC/WACCN/A

WACC8.27%

2.3 Liquidity

ALCPB has a Current Ratio of 3.42. This indicates that ALCPB is financially healthy and has no problem in meeting its short term obligations.

ALCPB's Current ratio of 3.42 is amongst the best of the industry. ALCPB outperforms 85.34% of its industry peers.

A Quick Ratio of 3.42 indicates that ALCPB has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 3.42, ALCPB belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.42
Quick Ratio	3.42

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.90% over the past year.

ALCPB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.82% yearly.

The Revenue for ALCPB has decreased by -32.07% in the past year. This is quite bad

Measured over the past years, ALCPB shows a very strong growth in Revenue. The Revenue has been growing by 43.44% on average per year.

EPS 1Y (TTM)106.9%

EPS 3YN/A

EPS 5Y2.82%

EPS Q2Q%100%

Revenue 1Y (TTM)-32.07%

Revenue growth 3Y-4.3%

Revenue growth 5Y43.44%

Sales Q2Q%-33.18%

3.2 Future

ALCPB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.

ALCPB is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.16% yearly.

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3Y25.99%

EPS Next 5YN/A

Revenue Next Year-64%

Revenue Next 2Y-35.51%

Revenue Next 3Y-22.16%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.10, which means the current valuation is very expensive for ALCPB.

Compared to the rest of the industry, the Price/Earnings ratio of ALCPB is on the same level as its industry peers.

ALCPB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.39.

		Industry Rank	Sector Rank
PE	38.1
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALCPB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALCPB's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.

PEG (NY)0.38

PEG (5Y)13.49

EPS Next 2Y41.42%

EPS Next 3Y25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALCPB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CAPITAL B

EPA:ALCPB (12/19/2025, 7:00:00 PM)

0.762

+0.01 (+1.2%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.83%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap172.87M

Revenue(TTM)13.86M

Net Income(TTM)1.36M

Analysts84.44

Price Target1.73 (127.03%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-80.68%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-26.58%

Revenue NY rev (3m)-26.58%

Valuation

		Industry Rank	Sector Rank
PE	38.1
Fwd PE	N/A
P/S	12.47
P/FCF	N/A
P/OCF	909.83
P/B	14.41
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)0.02

EY2.62%

EPS(NY)0

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)0

OCFY0.11%

SpS0.06

BVpS0.05

TBVpS-0.04

PEG (NY)0.38

PEG (5Y)13.49

Graham Number0.15

Profitability

		Industry Rank	Sector Rank
ROA	4%
ROE	11.33%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	9.81%
GM	60.18%
FCFM	N/A

ROA(3y)-22.55%

ROA(5y)-12.7%

ROE(3y)-96.83%

ROE(5y)-38.45%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y1.01%

GM growth 3Y3.05%

GM growth 5Y5.75%

F-Score5

Asset Turnover0.41

Health

		Industry Rank	Sector Rank
Debt/Equity	0.29
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	126.79%
Cap/Sales	15.36%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.42
Quick Ratio	3.42
Altman-Z	4.04

F-Score5

WACC8.27%

ROIC/WACCN/A

Cap/Depr(3y)108.31%

Cap/Depr(5y)N/A

Cap/Sales(3y)15.27%

Cap/Sales(5y)15.02%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)106.9%

EPS 3YN/A

EPS 5Y2.82%

EPS Q2Q%100%

EPS Next Y100%

EPS Next 2Y41.42%

EPS Next 3Y25.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-32.07%

Revenue growth 3Y-4.3%

Revenue growth 5Y43.44%

Sales Q2Q%-33.18%

Revenue Next Year-64%

Revenue Next 2Y-35.51%

Revenue Next 3Y-22.16%

Revenue Next 5YN/A

EBIT growth 1Y81.95%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-2136.47%

EBIT Next 3Y-117.27%

EBIT Next 5YN/A

FCF growth 1Y-466.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-92.78%

OCF growth 3Y-56.24%

OCF growth 5Y35.24%

CAPITAL B / ALCPB.PA FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALCPB.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALCPB.PA.

What is the valuation status for ALCPB stock?

ChartMill assigns a valuation rating of 2 / 10 to CAPITAL B (ALCPB.PA). This can be considered as Overvalued.

Can you provide the profitability details for CAPITAL B?

CAPITAL B (ALCPB.PA) has a profitability rating of 3 / 10.

What is the valuation of CAPITAL B based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CAPITAL B (ALCPB.PA) is 38.1 and the Price/Book (PB) ratio is 14.41.

Can you provide the expected EPS growth for ALCPB stock?

The Earnings per Share (EPS) of CAPITAL B (ALCPB.PA) is expected to grow by 100% in the next year.

CAPITAL B (ALCPB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CAPITAL B / ALCPB.PA FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALCPB.PA) stock?

What is the valuation status for ALCPB stock?

Can you provide the profitability details for CAPITAL B?

What is the valuation of CAPITAL B based on its PE and PB ratios?

Can you provide the expected EPS growth for ALCPB stock?